DR Horton Stock

Equities

DHI

US23331A1097

Homebuilding

Market Closed - Nyse 04:00:02 2024-07-02 pm EDT 5-day change 1st Jan Change
135.2 USD -1.32% Intraday chart for DR Horton -3.72% -11.03%
Sales 2024 * 36.91B Sales 2025 * 39.38B Capitalization 44.53B
Net income 2024 * 4.72B Net income 2025 * 5B EV / Sales 2024 * 1.24 x
Net Debt 2024 * 1.36B Net Debt 2025 * 1.02B EV / Sales 2025 * 1.16 x
P/E ratio 2024 *
9.52 x
P/E ratio 2025 *
8.71 x
Employees 13,450
Yield 2024 *
0.89%
Yield 2025 *
0.95%
Free-Float 73.76%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.32%
1 week-3.72%
Current month-4.06%
1 month-8.52%
3 months-13.13%
6 months-9.79%
Current year-11.03%
More quotes
1 week
133.02
Extreme 133.02
142.43
1 month
133.02
Extreme 133.02
149.88
Current year
133.02
Extreme 133.02
165.75
1 year
100.08
Extreme 100.08
165.75
3 years
59.25
Extreme 59.25
165.75
5 years
25.51
Extreme 25.51
165.75
10 years
19.29
Extreme 19.29
165.75
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 98-12-31
Chairman 68 87-12-31
Director of Finance/CFO 58 97-12-31
Members of the board TitleAgeSince
Director of Finance/CFO 58 97-12-31
Director/Board Member 78 14-01-22
Director/Board Member 73 21-04-19
More insiders
Date Price Change Volume
24-07-02 135.2 -1.32% 3,480,489
24-07-01 137 -2.77% 2,477,978
24-06-28 140.9 -0.19% 2,792,073
24-06-27 141.2 +0.63% 1,405,749
24-06-26 140.3 -0.09% 1,630,885

Delayed Quote Nyse, July 02, 2024 at 04:00 pm EDT

More quotes
D.R. Horton, Inc. is one of the leading American single-family homebuilders. Net sales break down by activity as follows: - construction of single-family homes and development of lots (90.4%): home sales (detached homes, attached homes, etc.; operating under the names D.R. Horton, America's Builder, Emerald Homes, Express Homes, Freedom Homes and Pacific Ridge Homes) and lot sales; - property rental (7.3%); - supply of financial services (2.3%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
135.2 USD
Average target price
168.4 USD
Spread / Average Target
+24.56%
Consensus